Viewing Study NCT06394167


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT06394167
Status: COMPLETED
Last Update Posted: 2025-03-20
First Post: 2024-04-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module